CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
4.220
+0.270 (6.84%)
At close: Apr 7, 2026, 4:00 PM EDT
4.109
-0.111 (-2.62%)
Pre-market: Apr 8, 2026, 8:27 AM EDT
CDT Equity Employees
CDT Equity had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$3,384,167
Market Cap
746.26K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Aditxt | 26 |
| Virax Biolabs Group | 19 |
| CNS Pharmaceuticals | 5 |
| Adial Pharmaceuticals | 5 |
| Onconetix | 2 |
| SciSparc | 2 |
CDT News
- 1 day ago - CDT Notes Sarborg Publication of PRISM Framework Expanding AI - GlobeNewsWire
- 13 days ago - CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings - GlobeNewsWire
- 14 days ago - CDT Equity Inc. Announces Reverse Stock Split - GlobeNewsWire
- 16 days ago - CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy - GlobeNewsWire
- 21 days ago - CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - GlobeNewsWire
- 27 days ago - CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - GlobeNewsWire
- 4 weeks ago - CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent - GlobeNewsWire
- 4 weeks ago - CDT Positions for Transformational Growth - GlobeNewsWire